NO133838B - - Google Patents
Download PDFInfo
- Publication number
- NO133838B NO133838B NO901/71A NO90171A NO133838B NO 133838 B NO133838 B NO 133838B NO 901/71 A NO901/71 A NO 901/71A NO 90171 A NO90171 A NO 90171A NO 133838 B NO133838 B NO 133838B
- Authority
- NO
- Norway
- Prior art keywords
- magnesium
- acid
- skin
- hair
- compounds
- Prior art date
Links
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 12
- 229910052749 magnesium Inorganic materials 0.000 claims description 12
- 239000011777 magnesium Substances 0.000 claims description 12
- 235000001014 amino acid Nutrition 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 210000004209 hair Anatomy 0.000 claims description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 235000015110 jellies Nutrition 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 239000003883 ointment base Substances 0.000 claims description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 2
- 235000020778 linoleic acid Nutrition 0.000 claims description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 2
- 229960004488 linolenic acid Drugs 0.000 claims description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 2
- 229940055726 pantothenic acid Drugs 0.000 claims description 2
- 235000019161 pantothenic acid Nutrition 0.000 claims description 2
- 239000011713 pantothenic acid Substances 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims 1
- 230000009467 reduction Effects 0.000 claims 1
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 7
- 239000013522 chelant Substances 0.000 description 5
- 150000002681 magnesium compounds Chemical class 0.000 description 4
- 159000000003 magnesium salts Chemical class 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 3
- -1 MgCl2 Chemical class 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 2
- OHXPGWPVLFPUSM-KLRNGDHRSA-N 3,7,12-trioxo-5beta-cholanic acid Chemical compound C1CC(=O)C[C@H]2CC(=O)[C@H]3[C@@H]4CC[C@H]([C@@H](CCC(O)=O)C)[C@@]4(C)C(=O)C[C@@H]3[C@]21C OHXPGWPVLFPUSM-KLRNGDHRSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical class [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960002997 dehydrocholic acid Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 150000004665 fatty acids Chemical group 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 210000002768 hair cell Anatomy 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008311 hydrophilic ointment Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229940040102 levulinic acid Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH359870A CH533639A (de) | 1970-03-11 | 1970-03-11 | Verfahren zur Herstellung neuer Benzo(4,5)cyclohepta(1,2-b)-thiophen-Derivate |
| CH1159370A CH531000A (de) | 1970-03-11 | 1970-07-31 | Verfahren zur Herstellung neuer Benzocycloheptathiophene |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO133838B true NO133838B (hu) | 1976-03-29 |
| NO133838C NO133838C (hu) | 1976-07-07 |
Family
ID=25693399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO90171A NO133838C (hu) | 1970-03-11 | 1971-03-10 |
Country Status (16)
| Country | Link |
|---|---|
| JP (1) | JPS5217030B1 (hu) |
| BG (1) | BG22398A3 (hu) |
| CS (1) | CS185562B2 (hu) |
| DD (1) | DD100000A5 (hu) |
| DK (1) | DK134404B (hu) |
| ES (2) | ES389044A1 (hu) |
| FI (1) | FI52980C (hu) |
| HU (1) | HU162868B (hu) |
| IE (2) | IE34997B1 (hu) |
| IL (1) | IL36370A (hu) |
| IT (1) | IT7827770A0 (hu) |
| MY (1) | MY8300201A (hu) |
| NO (1) | NO133838C (hu) |
| PL (1) | PL84083B1 (hu) |
| SU (1) | SU512711A3 (hu) |
| YU (2) | YU35019B (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2243778B1 (en) | 2008-01-30 | 2014-10-29 | Nippon Zoki Pharmaceutical Co., Ltd. | Piperidine derivative |
-
1971
- 1971-03-05 SU SU1628614A patent/SU512711A3/ru active
- 1971-03-09 HU HUSA002175 patent/HU162868B/hu unknown
- 1971-03-09 YU YU58671A patent/YU35019B/xx unknown
- 1971-03-09 PL PL14675171A patent/PL84083B1/pl unknown
- 1971-03-09 FI FI68371A patent/FI52980C/fi active
- 1971-03-09 ES ES389044A patent/ES389044A1/es not_active Expired
- 1971-03-09 CS CS171771A patent/CS185562B2/cs unknown
- 1971-03-09 IL IL36370A patent/IL36370A/xx unknown
- 1971-03-10 NO NO90171A patent/NO133838C/no unknown
- 1971-03-10 DK DK111471A patent/DK134404B/da not_active IP Right Cessation
- 1971-03-10 IE IE29971A patent/IE34997B1/xx unknown
- 1971-03-10 JP JP1302171A patent/JPS5217030B1/ja active Pending
- 1971-03-10 BG BG017004A patent/BG22398A3/xx unknown
- 1971-03-10 DD DD16465971A patent/DD100000A5/xx unknown
-
1973
- 1973-06-30 ES ES416480A patent/ES416480A1/es not_active Expired
-
1974
- 1974-07-15 IE IE149474A patent/IE34998B1/xx unknown
-
1978
- 1978-03-24 YU YU69978A patent/YU35254B/xx unknown
- 1978-09-15 IT IT7827770A patent/IT7827770A0/it unknown
-
1983
- 1983-12-30 MY MY8300201A patent/MY8300201A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK134404B (da) | 1976-11-01 |
| IT7827770A0 (it) | 1978-09-15 |
| YU35254B (en) | 1980-10-31 |
| DD100000A5 (hu) | 1973-09-05 |
| IE34998L (en) | 1975-10-15 |
| SU512711A3 (ru) | 1976-04-30 |
| ES416480A1 (es) | 1976-10-16 |
| NO133838C (hu) | 1976-07-07 |
| JPS5217030B1 (hu) | 1977-05-12 |
| DK134404C (hu) | 1977-04-04 |
| CS185562B2 (en) | 1978-10-31 |
| IE34998B1 (en) | 1975-10-15 |
| FI52980C (hu) | 1978-01-10 |
| BG22398A3 (bg) | 1977-02-20 |
| FI52980B (hu) | 1977-09-30 |
| PL84083B1 (hu) | 1976-02-28 |
| ES389044A1 (es) | 1974-02-01 |
| IE34997L (en) | 1971-09-11 |
| YU69978A (en) | 1980-04-30 |
| YU58671A (en) | 1979-12-31 |
| IE34997B1 (en) | 1975-10-15 |
| MY8300201A (en) | 1983-12-31 |
| IL36370A0 (en) | 1971-05-26 |
| IL36370A (en) | 1974-10-22 |
| HU162868B (hu) | 1973-04-28 |
| YU35019B (en) | 1980-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2027483A1 (fr) | Procede de preparation d'une solution aqueuse effervescente ayant une action emolliente sur la cuticule des ongles, composition pour la mise en oeuvre dudit procede et traitement cosmetique correspondant | |
| ES2075011T3 (es) | Uso de sales del acido gamma-hidroxibutirico para preparar composiciones farmaceuticas para uso en el tratamiento del alcoholismo, y las composiciones obtenidas. | |
| DE1099128B (de) | Mittel zur Pflege sowie zur Foerderung des Wachstums der Haut, der Haare und der Naegel | |
| MX2014015799A (es) | Composiciones farmaceuticas que comprenden rifaximina y aminoacidos, metodo de preparacion y uso de las mismas. | |
| WO2016079912A1 (ja) | 毛乳頭細胞活性化剤 | |
| KR20200031665A (ko) | 외용 조성물 | |
| WO2016177908A3 (fr) | Procede de traitement des matieres keratiniques a partir de derives de c-glycosides amides, acides ou ester, et la composition cosmetique les contenant | |
| KR20120113262A (ko) | 색소 침착 예방 또는 개선제 | |
| NO133838B (hu) | ||
| NO20011091L (no) | Umettede hydroksiminsyrederivater som PARP inhibitorer | |
| CN102985093A (zh) | 用于遏制光暴露导致的异常皮肤细胞的形成的试剂 | |
| CH609863A5 (en) | Cosmetic treatment process and products enabling it to be carried out | |
| MX169354B (es) | Procedimiento para el tratamiento de pieles | |
| JPS5663911A (en) | Cosmetic containing hard-soluble phycocyanin | |
| JP2012121856A (ja) | Ｖｅｇｆ産生促進剤、ｉｇｆ−１産生促進剤、ｈｇｆ産生促進剤、及びｂｍｐ−２産生促進剤 | |
| RU2642277C2 (ru) | Способ сохранения и стабилизации протеинов | |
| DE102010015120B4 (de) | Verwendung eines proteasehaltigen Haarwuchsreduktionsmittels | |
| US20060159646A1 (en) | Hair regenerator | |
| Mishchenko et al. | Study of the echinochrome stabilityand the products of its oxidative transformation | |
| GB604350A (en) | Process for reducing the viscosity of or for liquefying mucus and preparations for use therein | |
| TR202021285A1 (tr) | Yara skarinin önlenmesi̇ ve tedavi̇si̇nde kullanilmak üzere erbium borat i̇çeren formülasyon | |
| RU2021134935A (ru) | Способ лечения ожогов роговицы | |
| BOREL et al. | Influence of Some Purified Plasma Proteins on Collagen Synthesis in vitro | |
| MX2022003685A (es) | Hidrogel a base de gluconato de zinc y esteres de acido hialuronico. | |
| WO2019070018A1 (ja) | 光学活性ピロリドンカルボン酸またはそのアルカリ金属塩の製造方法 |